{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:48:43Z","timestamp":1782409723282,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["RISE-Health-UID\/06397\/2025"],"award-info":[{"award-number":["RISE-Health-UID\/06397\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.avsg.2026.02.046","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:40:20Z","timestamp":1772829620000},"page":"244-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk Stratification in Patients with TASC II D Aortoiliac Occlusive Disease Undergoing Revascularization: Validation of the CHA2DS2-VA Score for Long-Term Outcomes"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9908-9003","authenticated-orcid":false,"given":"M\u00e1rio","family":"Marques-Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Garrido-Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Pereira-Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Duarte-Gamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Brand\u00e3o-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marreiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"D'Oria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Rocha-Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl S","key":"10.1016\/j.avsg.2026.02.046_bib1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2026.02.046_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2026.02.046_bib4","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2026.02.046_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2026.02.046_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2026.02.046_bib7","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib8","first-page":"e726","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2026.02.046_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","article-title":"Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome","volume":"55","author":"Sartipy","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1076029616646874","article-title":"CHA2DS2-VASc score predicts In-Hospital and long-term clinical outcomes in patients with ST-Segment elevation myocardial infarction who were undergoing primary percutaneous coronary intervention","volume":"23","author":"Bozbay","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.avsg.2026.02.046_bib11","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1177\/0961203318763535","article-title":"CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation","volume":"27","author":"Hu","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.avsg.2026.02.046_bib12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2015.08.033","article-title":"Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database","volume":"66","author":"van den Ham","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2026.02.046_bib13","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort Study","volume":"64","author":"Bonde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2026.02.046_bib14","first-page":"742","article-title":"CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events","volume":"16","author":"Tasolar","year":"2016","journal-title":"Anatolian J Cardiol"},{"key":"10.1016\/j.avsg.2026.02.046_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2020.08.040","article-title":"Assessment of the modified CHA2DS2-VASc risk score in predicting mortality in patients hospitalized with COVID-19","volume":"135","author":"Cetinkal","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2026.02.046_bib16","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1538574419888815","article-title":"Endovascular approach versus aortobifemoral bypass grafting: outcomes in extensive aortoiliac occlusive disease","volume":"54","author":"Rocha-Neves","year":"2020","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijsu.2019.11.002","article-title":"STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery","volume":"72","author":"Agha","year":"2019","journal-title":"Int J Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global Vascular Guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib21","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2026.02.046_bib22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jvs.2018.06.193","article-title":"Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication","volume":"68","author":"Fashandi","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejvs.2016.09.007","article-title":"Diagnosis of aortic graft infection: a case definition by the management of aortic graft infection Collaboration (MAGIC)","volume":"52","author":"Lyons","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/00033197241273382","article-title":"Relationship between CHA(2)DS(2)-VASc Score on admission and In-Hospital major adverse cardiovascular events in patients diagnosed with ST-Elevation myocardial infarction","volume":"76","author":"Inan","year":"2025","journal-title":"Angiology"},{"key":"10.1016\/j.avsg.2026.02.046_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.avsg.2023.02.016","article-title":"R2CHA2DS2-VA predictsthe cardiovascular risk after Carotid endarterectomy","volume":"94","author":"Quesado","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2026.02.046_bib26","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.3390\/jcm10184093","article-title":"CHA2DS2-VASc score for major adverse cardiovascular events stratification in patients with pneumonia with and without atrial fibrillation","volume":"10","author":"Wang","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.avsg.2026.02.046_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1024\/0301-1526\/a001183","article-title":"Hospital frailty risk and CHA2DS2-VA scores in the mortality assessment of older patients with peripheral artery disease","volume":"54","author":"Piepenburg","year":"2025","journal-title":"Vasa"},{"key":"10.1016\/j.avsg.2026.02.046_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's Choice \u2013 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050962600141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089050962600141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:25:51Z","timestamp":1782408351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089050962600141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"alternative-id":["S089050962600141X"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2026.02.046","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Stratification in Patients with TASC II D Aortoiliac Occlusive Disease Undergoing Revascularization: Validation of the CHA2DS2-VA Score for Long-Term Outcomes","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2026.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}